152 related articles for article (PubMed ID: 18589557)
1. Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats.
Lupp A; Karge E; Deufel T; Oelschlägers H; Fleck C
Arzneimittelforschung; 2008; 58(5):225-41. PubMed ID: 18589557
[TBL] [Abstract][Full Text] [Related]
2. Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood.
Lupp A; Karge E; Danz M; Deufel T; Oelschläger H; Klinger W
Eur J Drug Metab Pharmacokinet; 2005; 30(3):203-18. PubMed ID: 16250258
[TBL] [Abstract][Full Text] [Related]
3. Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study.
Klinger W; Lupp A; Karge E; Oelschläger H; Rothley D; Danz M; Linss W; Löbel S; Deufel T; Müller M; Klinger M; Kühnel W
Exp Toxicol Pathol; 1998 Sep; 50(4-6):301-14. PubMed ID: 9784002
[TBL] [Abstract][Full Text] [Related]
4. Fibrates and their newly synthesized glycinate or glycinate-methylester derivatives: comparison of the interactions with liver cytochrome P450 dependent monooxygenase- and oxidase-functions in vitro.
Lupp A; Karge E; Hopf H; Machts H; Oelschläger H; Fleck C
Exp Toxicol Pathol; 2003 Jun; 54(5-6):433-40. PubMed ID: 12877356
[TBL] [Abstract][Full Text] [Related]
5. Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity as compared to Zucker lean and Sprague-Dawley rats.
Pacot C; Petit M; Caira F; Rollin M; Behechti N; Grégoire S; Cherkaoui Malki M; Cavatz C; Moisant M; Moreau C
Biol Cell; 1993; 77(1):27-35. PubMed ID: 8518742
[TBL] [Abstract][Full Text] [Related]
6. The effects of diquat and ciprofibrate on mRNA expression and catalytic activities of hepatic xenobiotic metabolizing and antioxidant enzymes in rat liver.
Gallagher EP; Buetler TM; Stapleton PL; Wang C; Stahl DL; Eaton DL
Toxicol Appl Pharmacol; 1995 Sep; 134(1):81-91. PubMed ID: 7676460
[TBL] [Abstract][Full Text] [Related]
7. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
9. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.
Makowska JM; Bonner FW; Gibson GG
Arch Toxicol; 1991; 65(2):106-13. PubMed ID: 1905530
[TBL] [Abstract][Full Text] [Related]
10. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
Srinivasan SR; Chow CK; Glauert HP
Toxicology; 1990 Jun; 62(3):321-32. PubMed ID: 2389247
[TBL] [Abstract][Full Text] [Related]
11. Comparative and simultaneous effects of simvastatin and ciprofibrate on plasma lipid parameters and upon hepatic drug metabolizing and peroxisome proliferation marker enzymes in the male Wistar rat.
Charmoillaux M; Goudonnet H; Mercenne F; Mounié J; Truchot RC
Cell Mol Biol; 1991; 37(8):765-71. PubMed ID: 1807786
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
[TBL] [Abstract][Full Text] [Related]
13. Zonal differences in DNA synthesis activity and cytochrome P450 gene expression in livers of male F344 rats treated with five nongenotoxic carcinogens.
Chen ZY; White CC; He CY; Liu YF; Eaton DL
J Environ Pathol Toxicol Oncol; 1995; 14(2):83-99. PubMed ID: 9372837
[TBL] [Abstract][Full Text] [Related]
14. Xenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.
Zangar RC; Woodcroft KJ; Kocarek TA; Novak RF
Drug Metab Dispos; 1995 Jul; 23(7):681-7. PubMed ID: 7587954
[TBL] [Abstract][Full Text] [Related]
15. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of fetal liver tissue suspension into the spleens of adult syngenic rats: effects of different cytotoxins on cytochrome P450 isoforms expression and on glycogen content.
Lupp A; Lucas N; Danz M; Klinger W
Exp Toxicol Pathol; 2000 Oct; 52(5):381-93. PubMed ID: 11089889
[TBL] [Abstract][Full Text] [Related]
17. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats.
Leung LK; Glauert HP
Toxicology; 1998 Feb; 126(1):65-73. PubMed ID: 9585093
[TBL] [Abstract][Full Text] [Related]
18. Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats.
Herbert JM; Bernat A; Chatenet-Duchène L
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):239-44. PubMed ID: 10456614
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression.
Zangar RC; Woodcroft KJ; Novak RF
Toxicol Appl Pharmacol; 1996 Nov; 141(1):110-6. PubMed ID: 8917682
[TBL] [Abstract][Full Text] [Related]
20. Effects of ciprofibrate on testicular and adrenal steroidogenic enzymes in the rat.
Hierlihy AM; Cooke GM; Curran IH; Mehta R; Karamanos L; Price CA
Reprod Toxicol; 2006 Jul; 22(1):37-43. PubMed ID: 16337773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
